UniProtKB/Swiss-Prot Q11203 : Variant p.Asp370Tyr
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
Gene: ST3GAL3
Feedback ?
Variant information
Variant position:
370
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Aspartate (D) to Tyrosine (Y) at position 370 (D370Y, p.Asp370Tyr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and acidic (D) to large size and aromatic (Y)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In MRT12; the mutant protein is improperly localized to the endoplasmic reticulum preventing the protein from interacting with its substrates in the Golgi and resulting in a loss-of-function; shows a complete lack of enzyme activity; secretion of the mutant protein is dramatically reduced compared to wild-type.
Any additional useful information about the variant.
Sequence information
Variant position:
370
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
375
The length of the canonical sequence.
Location on the sequence:
HNIQREKEFLRKLVKARVIT
D LSSGI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human HNIQREKEFLRKLVKARVITD LSSGI
Chimpanzee HNIQREKEFLRKLVKARVITD LSSGI
Mouse HNIQREKEFLRKLVKARVITD LSSGI
Rat HNIQREKEFLRKLVKARVITD LSSGI
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 375
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
Topological domain
29 – 375
Lumenal
Alternative sequence
44 – 375
Missing. In isoform E1.
Alternative sequence
74 – 375
Missing. In isoform E3+32.
Alternative sequence
116 – 375
Missing. In isoform B4+173.
Alternative sequence
118 – 375
Missing. In isoform C12.
Alternative sequence
122 – 375
Missing. In isoform B5+173.
Alternative sequence
152 – 375
Missing. In isoform B10.
Alternative sequence
156 – 375
Missing. In isoform A7, isoform B7 and isoform C7.
Alternative sequence
187 – 375
Missing. In isoform B5+26 and isoform D2+26.
Alternative sequence
190 – 375
Missing. In isoform B1+32.
Alternative sequence
203 – 375
Missing. In isoform C5 and isoform D5.
Alternative sequence
245 – 375
Missing. In isoform C9.
Literature citations
ST3GAL3 mutations impair the development of higher cognitive functions.
Hu H.; Eggers K.; Chen W.; Garshasbi M.; Motazacker M.M.; Wrogemann K.; Kahrizi K.; Tzschach A.; Hosseini M.; Bahman I.; Hucho T.; Muhlenhoff M.; Gerardy-Schahn R.; Najmabadi H.; Ropers H.H.; Kuss A.W.;
Am. J. Hum. Genet. 89:407-414(2011)
Cited for: VARIANTS MRT12 ASP-13 AND TYR-370; CHARACTERIZATION OF VARIANTS MRT12 ASP-13 AND TYR-370;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.